Related Experiment Video
Updated: May 27, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation
J G Mainz1, J Hentschel, C Schien
1CF Centre, Pediatric Pneumology, Jena University Hospital, Germany. Jochen.Mainz@med.uni-jena.de
Unlabelled:
We report on two CF patients who received double lung transplantation (LTX) due to Pseudomonas aeruginosa related pulmonary destruction. Prior to LTX we detected P. aeruginosa in nasal lavages (NL) and sputum cultures from both patients. Donor lungs of patient 1 became colonized within four weeks with P. aeruginosa identical in genotype with isolates from his pre-transplant sputum cultures and pre- and post-transplant NL. In contrast, patient 2 remained P. aeruginosa free in lower airway samples (bronchial lavage/sputum) for now up to 30 months, despite persistent detection of P. aeruginosa that was identical in genotype with pre-transplant NL and sputum isolates in NL and even in throat swabs. For prevention of pulmonary re-colonization patient 2 has continuously inhaled Colomycin 1 MIU once daily during the preceding more than 36 months with the novel Pari Sinus™ nebulizer, which in scintigraphic studies was shown to deliver vibrating aerosols into paranasal sinuses, additional to bronchial antibiotic inhalation.
Discussion:
Pulmonary colonization of transplanted donor lungs with identical clones previously colonizing the explanted lungs has been described previously and the upper airways were postulated as reservoir for descending colonization. However, this remained speculative, as upper airway sampling which does not belong to current standards, was not performed in these studies. Our report demonstrates persistence of identical P. aeruginosa genotypes in CF upper airways prior to and after LTX underlining risks of descending colonization of transplanted lungs with P. aeruginosa, which increases risks of graft dysfunction. Therefore, we recommend regular assessment of sinonasal colonization prior to and after LTX. Sinonasal inhalation with antimicrobials should be investigated in prospective trials.
Insights
Pseudomonas aeruginosa in the upper airways of cystic fibrosis patients can colonize transplanted lungs. Regular sinonasal assessment and antimicrobial inhalation are recommended post-lung transplantation to prevent graft dysfunction.
Area of Science:
- Pulmonology
- Infectious Diseases
- Transplantation Immunology
Background:
- Cystic Fibrosis (CF) patients often suffer from Pseudomonas aeruginosa infections.
- Lung transplantation (LTX) is a life-saving procedure for advanced CF.
- Pre-existing P. aeruginosa colonization poses a risk for LTX recipients.
Observation:
- Two CF patients undergoing LTX for P. aeruginosa-related lung destruction were studied.
- Patient 1 experienced donor lung colonization with P. aeruginosa from pre-transplant isolates.
- Patient 2 remained P. aeruginosa-free in lower airways post-LTX, despite persistent upper airway colonization.
Findings:
- Identical P. aeruginosa genotypes were found in pre- and post-LTX upper airway samples (nasal lavages, throat swabs) in both patients.
- Upper airways act as a reservoir for P. aeruginosa, increasing the risk of donor lung colonization.
- Patient 2's regimen included sinonasal Colomycin inhalation, potentially preventing lower airway re-colonization.
Implications:
- Regular sinonasal P. aeruginosa screening is crucial before and after LTX.
- The upper airway reservoir highlights the need for targeted antimicrobial strategies.
- Investigating sinonasal antimicrobial inhalation may reduce P. aeruginosa-related graft dysfunction post-LTX.
Related Concept Videos
Microbiota of the Respiratory Tract
Atypical Pneumonia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

